Functional Genomics for the Identification of Therapeutic Vulnerabilities in Acute Myeloid Leukemia

Study of therapeutic vulnerabilities in acute myeloid leukemia (AML) using functional genomics approaches, including CRISPR screening and genome editing, aimed at identifying genetic interactions, mechanisms of resistance, and rational drug combinations to enhance the efficacy of anticancer therapies.